The Future of Cancer Screening-Guided Without Conflicts of Interest

JAMA Intern Med. 2023 Oct 1;183(10):1047-1048. doi: 10.1001/jamainternmed.2023.4064.

Authors

Hans-Olov Adami^{1

2}, Mette Kalager¹, Michael Bretthauer¹

Affiliations

¹ Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway.
² Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

PMID: 37639267
DOI: 10.1001/jamainternmed.2023.4064

No abstract available

Plain language summary

This Viewpoint discusses the benefits and harms of cancer screening tests in the context of various stakeholders.